- Part 36: For the preceding part double click ID:nRSH4027RI
most significant of which are detailed in Note 27 to the Financial
Statements from page 186.
Misuse of social media platforms and new technology Impact
We increasingly use the internet, digital content, social media, mobile Inappropriate use of certain media vehicles could lead to the unauthorised or unintentional public disclosure of sensitive information (such as personally identifiable information on employees, healthcare professionals or patients, for example, those enrolled in our clinical trials), which may damage our reputation, adversely affect our business or results of operations and expose us to legal risks, as well as additional legal obligations. Similarly, the involuntary public disclosure of commercially sensitive information, such as trade secrets through external media channels, or an information loss could adversely affect our business or results of operations. In addition, negative posts or comments on social media websites or other digital channels or new forms of technology about us or, for example, the safety of our products, could harm our reputation.
applications and other forms of new technology to communicate internally
and externally. The accessibility and instantaneous nature of
interactions with such media may facilitate or exacerbate the risk of
data leakages from within AstraZeneca or false or misleading statements
being made about AstraZeneca, which may damage our reputation. As
existing social media platforms expand and evolve, and new social media
- More to follow, for following part double click ID:nRSH4027RK